Search
Tag: plamotamab
Xencor regains rights to most cancers drug plamotamab By Investing.com
PASADENA, Calif. - Xencor Inc . (NASDAQ:), a biopharmaceutical agency, introduced it would reclaim full rights to its most cancers…
PASADENA, Calif. - Xencor Inc . (NASDAQ:), a biopharmaceutical agency, introduced it would reclaim full rights to its most cancers…
Please contact salesdepartment
for further information at:
Sales@88.broker
